New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Heatwurx Inc.

PCSA

Healthcare Biotechnology

EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.67 0.03 −1.76%
Market cap
$4.8M
P/E
n/m
Fwd P/E FY16e
—
Dividend yield
—
F-score
n/a
ROIC
0.00%
Net debt / EBITDA
0.4×
Payout ratio
—

What it owns vs. what it owes Q3 FY2026, 30 September 2026

Liabilities are $181.4M more than assets: shareholders’ equity is negative. What is a balance sheet?

30 September 2026 · total $182.0M

Owns

$3.0KLong-term assets
$1.8MOther short-term assets
$180.2MCash & short-term investments

Funded by

$363.4MOther liabilities

Debt is 0.0% of the total; liabilities are $181.4M more than assets.

Older periods Dec '25 Mar '26 Jun '26 Sep '26
Total current assets
5.67 1.94 2.07 182.01
Total non-current assets
2.14 2.58 0.00 0.00
Total Assets
7.81 4.52 2.07 182.01
Total current liabilities
2.24 1.98 2.39 1.86
Total non-current liabilities
— — — 361.53
Total liabilities
2.24 1.98 2.39 363.40
Common Equity (Total)
5.58 2.54 (0.32) (181.38)
Shareholders Equity (Total)
5.58 2.54 (0.32) (181.38)

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 18 Nov 2026